EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Diagnostic and Prognostic Role of Biomarkers in Chronic Rhinosinusitis

Jun Jie Seah iD, Mark Thong, De Yun Wang iD

Diagnostics · 14.02.2023 · 13 (4) · 715

DOI: 10.3390/diagnostics13040715 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 14.02.2023. Verfasst von Jun Jie Seah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic rhinosinusitis (CRS) refers to an inflammatory disease of the sinonasal mucosa, with a significant economic burden and impact on quality of life. The diagnosis of CRS is conventionally made on careful history and physical examination, including nasoendoscopic assessment which requires technical expertise. There has been increasing interest in using biomarkers in the non-invasive diagnosis and prognostication of CRS, tailored to the disease inflammatory endotype. Potential biomarkers currently being studied can be isolated from peripheral blood, exhaled nasal gases or nasal secretions, as well as sinonasal tissue. In particular, various biomarkers have revolutionized the way in which CRS is managed, revealing new inflammatory pathways where novel therapeutic drugs are employed to curb the inflammatory process, which may be different from one patient to the next. Biomarkers that have been extensively studied in CRS, such as eosinophil count, IgE, and IL-5, have been associated with a TH2 inflammatory endotype which correlates with an eosinophilic CRSwNP phenotype that predicts a poorer prognosis, tends to recur after conventional surgical treatment, but responds to glucocorticoid treatment. Newer biomarkers that demonstrate potential, such as nasal nitric oxide, can support a diagnosis of CRS with or without nasal polyps, especially when invasive tests such as nasoendoscopy are unavailable. Other biomarkers such as periostin can be used to monitor disease course after treatment of CRS. With a personalized treatment plan, the management of CRS can be individualized, optimizing treatment efficiency and reducing adverse outcomes. As such, this review aims to compile and summarize the existing literature regarding the utility of biomarkers in CRS in terms of diagnosis and prognostication, and also makes recommendations for further studies to fill current knowledge gaps.

Schlagwörter

Stichwörter der Autor:innen

biomarkerschronic rhinosinusitisdiagnosticprognostication

Autor:innen und Institutionen

  • Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Department of Otolaryngology-Head and Neck Surgery, National University Hospital, National University Health System, Singapore 119228, Singapore.
  • Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.

ORCID-Profile: Jun Jie Seah, De Yun Wang

Zitieren

APA

Seah, J. J., Thong, M., & Wang, Y. (2023). The Diagnostic and Prognostic Role of Biomarkers in Chronic Rhinosinusitis. Diagnostics, 13(4), 715. https://doi.org/10.3390/diagnostics13040715

Vancouver

Seah JJ, Thong M, Wang Y. The Diagnostic and Prognostic Role of Biomarkers in Chronic Rhinosinusitis. Diagnostics. 2023;13(4):715. doi:10.3390/diagnostics13040715

BibTeX
@article{Seah2023,
  author = {Seah, Jun Jie and Thong, Mark and Wang, De Yun},
  title = {The Diagnostic and Prognostic Role of Biomarkers in Chronic Rhinosinusitis},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {715},
  doi = {10.3390/diagnostics13040715}
}
Kostenlos starten →